Ponessa Sara 4
4 · Arcadium Lithium plc · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Ponessa Sara
General Counsel, VP & Sec
Transactions
- Award
Stock Option (Right to Buy)
2024-01-04+27,887→ 27,887 totalExercise: $8.74From: 2025-02-23Exp: 2032-02-23→ Ordinary Shares (27,887 underlying) - Award
Ordinary Shares
2024-01-04+66,562→ 116,351 total - Award
Stock Option (Right to Buy)
2024-01-04+85,935→ 85,935 totalExercise: $8.46From: 2024-02-22Exp: 2031-02-22→ Ordinary Shares (85,935 underlying) - Award
Stock Option (Right to Buy)
2024-01-04+29,358→ 29,358 totalExercise: $9.70From: 2026-02-22Exp: 2033-02-22→ Ordinary Shares (29,358 underlying) - Award
Ordinary Shares
2024-01-04+49,789→ 49,789 total
Footnotes (3)
- [F1]Represents the conversion of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (as amended, the "Transaction Agreement").
- [F2]Represents the conversion of restricted share units with respect to shares of Livent Common Stock ("Livent RSUs"), held by the reporting person as of January 4, 2024, into restricted share units with respect to Arcadium Ordinary Shares ("Arcadium RSUs"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.
- [F3]Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.